JUBLPHARMA Breakout after 2018
Below are the some points to go through for better analysis:
1. Breakout after 2018
2. Risk Reward is almost 2.5.
3. Did not fall even Nifty fall
Disclaimer:
Content shared on or through social site channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
1. Breakout after 2018
2. Risk Reward is almost 2.5.
3. Did not fall even Nifty fall
Disclaimer:
Content shared on or through social site channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
Thông báo miễn trừ trách nhiệm
Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.